Cardio-Oncology Registry

Condition(s) studied

Investigational drug(s) / intervention(s)

No interventions are planned: Non applicable

Study summary

Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias.

CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt.

The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.

Eligibility

Primary outcome measure(s)

• Incidence of cardio-toxicty — 5 years
  Number of patients with cardiotoxicity in a cohort of patients referred to a cardio-oncology clinic

Trial sites (1)

More European Georges Pompidou Hospital trials in France

Other trials for the same condition